معرفی
Dr. Stefania Bellone is an Associate Research Scientist in the Department of Obstetrics, Gynecology & Reproductive Sciences at Yale School of Medicine, Yale University. She holds a PhD from the University of Brescia (2003) and an MS from the University of Genova (1999). Her research focuses on translational oncology, particularly ovarian and uterine cancers, with an emphasis on immunotherapeutic strategies, molecular genetics, and clinical trials.
Her work spans basic studies in tumor immunology to clinical trials, including investigations into novel therapies like Clostridium Perfringens Enterotoxin (CPE) and antibody-drug conjugates (e.g., datopotamab deruxtecan). Dr. Bellone leads trials evaluating treatments for platinum-resistant ovarian cancer, endometrial cancer, and Long COVID in gynecologic patients. Her studies often involve collaborations with clinicians and researchers such as Dr. Alessandro Santin.
Key research themes include clonality analysis in tumors, mechanisms of chemotherapy resistance, and targeted therapies for refractory malignancies. She has secured NIH and DoD funding for her work and has published extensively in high-impact journals like the New England Journal of Medicine and Clinical Cancer Research.